Translational Medicine
Open Access

Laboratory diagnostics in oncology

14^th Annual Conference on Translational Medicine and Oncologists Meet

November 28-30, 2016 San Francisco, USA

David Stejskal

Agel Training and Research Institute, Czech Republic

Scientific Tracks Abstracts: Transl Med

Abstract :

miRNA is new potential markers of kidney diseases. We present our experience with the examination of miRNA in diabetics and patients with autoimmune kidney disease.

Biography :

Prof. David Stejskal MBA has completed his Ph.D at the age of 33 years from Palacký University and postdoctoral studies from Charles University, School of Medicine, Czech Republic. He is the head of Department of Laboratory Medicine Central Moravian Hospital Trust, Czech Republic. This is the branch of Agel Training and Research Institute. He has published more than 170 papers in reputed journals and serving as an editorial board member of repute journals.

Email: david.stejskal@nemsne.cz